Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Nov 29th 2019, Crypto Chartbook – Portfolio reload, step up to the plate

Portfolio reload, step up to the plate When the universe aligns or better said many edges speak in favor for a trading entry, it´s time to take action. Unfortunately, this is easier said than done. As contrarians, these times are often, or should we say best , when others...
Korbinian Koller | December 2, 2019 |

Daimler, Lufthansa, Royal Helium - the crisis is an opportunity for wealth

As is well known, the future is traded on the stock exchange and for this reason investors are always looking for the right time to start a new investment. It can be political decisions or new technological trends that cause sales and profits to soar. In the case of Covid-19, ...
Mario Hose | September 8, 2020 |

Events that Shook the Global Financial Markets in 2019

It was another big year for the global financial markets that culminated in a phase 1 trade agreement and assured Britain’s departure from the EU. Bob Mason It was yet another spectacular yea...
FX Empire | December 30, 2019 |

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |

Perfectly Bearish Rally in the Precious Metals Sector

Yes, you have read that right. Rallies are not necessarily bullish, and declines are not necessarily bearish. If it was the case, it would be possible to make a living by going long every time a market moves higher on the previous day, and going short when it declines. But the...
Przemyslaw Radomski, CFA | May 6, 2019 |

Buzz on the Bullboards: Eye of the Storm

With the big weeks for energy companies behind us and the cannabis sector ongoing, the last week of trading has felt like the eye of the storm. When you add political tensions ramping up in Washington and uncertain global markets, it makes sense that investors had a tough time...
Omri Wallach | November 13, 2019 |

Buzz on the Bullboards: Big Last-Minute Moves

Though some may have expected the markets to be relaxed heading into the holidays, many investors and brokers know that this is their time to shine. With every twist and turn the global economy has been throwing our way, staying active is definitely the right move. And as ...
Omri Wallach | December 11, 2019 |

Revolutionizing vascular grafting with a durable solution

Our next guest is a multi-technology biomedical company, focused on the development and commercialization of medical technologies. Marizyme Inc. (OTCQB:MRZM) has had its sights set on development of medical technology and products, one of which is DuraGraft. J...
Brieanna McCutcheon | September 27, 2023 |

Anixa Licenses Another Potential Blockbuster

In January we proclaimed Anixa Biosciences Inc. (ANIX:NASDAQ) to be Tailwinds' stock of the year. This designation was awarded due to potential major milestones in both the detection and the curing of cancer. With its Cchek prostate diagnostic shooting for CLIA approval...
Streetwise Reports | July 25, 2019 |

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...
Stockhouse Editorial | September 8, 2020 |
1 2 3